{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:59:04Z","timestamp":1790643544166,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of Ningxia Hui Autonomous Region","award":["2025AAC030642"],"award-info":[{"award-number":["2025AAC030642"]}]},{"name":"Oncology characteristic discipline Construction Project of Ningxia Medical University","award":["TSXK2025005"],"award-info":[{"award-number":["TSXK2025005"]}],"id":[{"id":"https:\/\/ror.org\/02h8a1848","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Science and Technology Infrastructure Construction Project of Ningxia Hui Autonomous Region","award":["2025DPC05024"],"award-info":[{"award-number":["2025DPC05024"]}]},{"name":"Key Research and Development Program of Ningxia Hui Autonomous Region","award":["2025BEG01001"],"award-info":[{"award-number":["2025BEG01001"]}]},{"name":"Key Research and Development Program of Ningxia Hui Autonomous Region","award":["2026BEG02009"],"award-info":[{"award-number":["2026BEG02009"]}]},{"name":"Tumor Discipline Cluster of Ningxia Medical University General Hospital","award":["YSXK2024003"],"award-info":[{"award-number":["YSXK2024003"]}],"id":[{"id":"https:\/\/ror.org\/049dkqr57","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Key R&D Program of Ningxia Hui Autonomous Region for high-level Talents Introduction","award":["2024BEH04154"],"award-info":[{"award-number":["2024BEH04154"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08572-6","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T12:19:14Z","timestamp":1783081154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Improving pancreatic adenocarcinoma prognosis models through ligand receptor interactions and histopathological integration"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5770-7865","authenticated-orcid":false,"given":"Kejun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yezhen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9095-0469","authenticated-orcid":false,"given":"Yongxue","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1219-997X","authenticated-orcid":false,"given":"Yang","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"8572_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"CA Cancer J Clin"},{"key":"8572_CR2","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1001\/jama.2020.21717","volume":"324","author":"BM Kuehn","year":"2020","unstructured":"Kuehn BM. Looking to long-term survivors for improved pancreatic cancer treatment. JAMA. 2020;324:2242\u20134. https:\/\/doi.org\/10.1001\/jama.2020.21717.","journal-title":"JAMA"},{"key":"8572_CR3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","volume":"18","author":"AP Klein","year":"2021","unstructured":"Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol. 2021;18:493\u2013502. https:\/\/doi.org\/10.1038\/s41575-021-00457-x.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8572_CR4","doi-asserted-by":"publisher","first-page":"688377","DOI":"10.3389\/fonc.2021.688377","volume":"11","author":"DR Principe","year":"2021","unstructured":"Principe DR, Underwood PW, Korc M, Trevino JG, Munshi HG, Rana A. The current treatment paradigm for pancreatic ductal adenocarcinoma and barriers to therapeutic efficacy. Front Oncol. 2021;11:688377. https:\/\/doi.org\/10.3389\/fonc.2021.688377.","journal-title":"Front Oncol"},{"key":"8572_CR5","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.3390\/cancers16162876","volume":"16","author":"N Vitorakis","year":"2024","unstructured":"Vitorakis N, Gargalionis AN, Papavassiliou KA, Adamopoulos C, Papavassiliou AG. Precision targeting strategies in pancreatic cancer: the role of tumor microenvironment. Cancers (Basel). 2024;16:2876. https:\/\/doi.org\/10.3390\/cancers16162876.","journal-title":"Cancers (Basel)"},{"key":"8572_CR6","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/s41571-025-01077-z","volume":"22","author":"H-C Kung","year":"2025","unstructured":"Kung H-C, Zheng KW, Zimmerman JW, Zheng L. The tumour microenvironment in pancreatic cancer - new clinical challenges, but more opportunities. Nat Rev Clin Oncol. 2025;22:969\u201395. https:\/\/doi.org\/10.1038\/s41571-025-01077-z.","journal-title":"Nat Rev Clin Oncol"},{"key":"8572_CR7","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.1038\/s41467-023-39881-9","volume":"14","author":"J Zheng","year":"2023","unstructured":"Zheng J, Zheng Z, Fu C, Weng Y, He A, Ye X, et al. Deciphering intercellular signaling complexes by interaction-guided chemical proteomics. Nat Commun. 2023;14:4138. https:\/\/doi.org\/10.1038\/s41467-023-39881-9.","journal-title":"Nat Commun"},{"key":"8572_CR8","doi-asserted-by":"publisher","first-page":"e70788","DOI":"10.1002\/cam4.70788","volume":"14","author":"S Sigirli","year":"2025","unstructured":"Sigirli S, Karakas D. Fibrotic fortresses and therapeutic frontiers: pancreatic stellate cells and the extracellular matrix in pancreatic cancer. Cancer Med. 2025;14:e70788. https:\/\/doi.org\/10.1002\/cam4.70788.","journal-title":"Cancer Med"},{"key":"8572_CR9","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41590-025-02134-6","volume":"26","author":"M Shakiba","year":"2025","unstructured":"Shakiba M, Tuveson DA. Macrophages and fibroblasts as regulators of the immune response in pancreatic cancer. Nat Immunol. 2025;26:678\u201391. https:\/\/doi.org\/10.1038\/s41590-025-02134-6.","journal-title":"Nat Immunol"},{"key":"8572_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2025-335683","author":"K Chen","year":"2026","unstructured":"Chen K, Ma Y, Huang L, Wu P, Kung H-C, Yang B, et al. Complement-secreting CAFs are associated with better prognosis in pancreatic cancer: single-cell multiomics. Gut. 2026. https:\/\/doi.org\/10.1136\/gutjnl-2025-335683. gutjnl-2025-335683.","journal-title":"Gut"},{"key":"8572_CR11","doi-asserted-by":"publisher","unstructured":"Hu B, Wu C, Mao H, Gu H, Dong H, Yan J, et al. Subpopulations of cancer-associated fibroblasts link the prognosis and metabolic features of pancreatic ductal adenocarcinoma. Ann Transl Med [Internet]. 2022 [cited 2026 Mar 25];10:262. https:\/\/doi.org\/10.21037\/atm-22-407.","DOI":"10.21037\/atm-22-407"},{"key":"8572_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-024-01888-z","volume":"9","author":"J Su","year":"2024","unstructured":"Su J, Song Y, Zhu Z, Huang X, Fan J, Qiao J, et al. Cell-cell communication: new insights and clinical implications. Signal Transduct Target Ther. 2024;9:196. https:\/\/doi.org\/10.1038\/s41392-024-01888-z.","journal-title":"Signal Transduct Target Ther"},{"key":"8572_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/jcmm.12408","volume":"19","author":"K Kami\u0144ska","year":"2015","unstructured":"Kami\u0144ska K, Szczylik C, Bielecka ZF, Bartnik E, Porta C, Lian F, et al. The role of the cell-cell interactions in cancer progression. J Cell Mol Med. 2015;19:283\u201396. https:\/\/doi.org\/10.1111\/jcmm.12408.","journal-title":"J Cell Mol Med"},{"key":"8572_CR14","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.1038\/s41467-020-18916-5","volume":"11","author":"Z Chen","year":"2020","unstructured":"Chen Z, Zhou L, Liu L, Hou Y, Xiong M, Yang Y, et al. Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nat Commun. 2020;11:5077. https:\/\/doi.org\/10.1038\/s41467-020-18916-5.","journal-title":"Nat Commun"},{"key":"8572_CR15","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1038\/s41467-022-30755-0","volume":"13","author":"D Dimitrov","year":"2022","unstructured":"Dimitrov D, T\u00fcrei D, Garrido-Rodriguez M, Burmedi PL, Nagai JS, Boys C, et al. Comparison of methods and resources for cell-cell communication inference from single-cell RNA-Seq data. Nat Commun. 2022;13:3224. https:\/\/doi.org\/10.1038\/s41467-022-30755-0.","journal-title":"Nat Commun"},{"key":"8572_CR16","doi-asserted-by":"publisher","first-page":"1579184","DOI":"10.3389\/fimmu.2025.1579184","volume":"16","author":"H Du","year":"2025","unstructured":"Du H, Si G, Si J, Song X, Si F. Integration of single-cell RNA and bulk RNA sequencing revealed malignant ductal cell heterogeneity and prognosis signatures in pancreatic cancer. Front Immunol. 2025;16:1579184. https:\/\/doi.org\/10.3389\/fimmu.2025.1579184.","journal-title":"Front Immunol"},{"key":"8572_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12865-025-00733-4","volume":"26","author":"Z Deng","year":"2025","unstructured":"Deng Z, Li L, Yang Z, Zeng G, Liu R. Integrated analysis of polytranscriptomics reveals TNFSF ligand genes in pancreatic cancer prognosis and immune regulation. BMC Immunol. 2025;26:50. https:\/\/doi.org\/10.1186\/s12865-025-00733-4.","journal-title":"BMC Immunol"},{"key":"8572_CR18","doi-asserted-by":"publisher","first-page":"101126","DOI":"10.1016\/j.bbrep.2021.101126","volume":"28","author":"SR Suzuki","year":"2021","unstructured":"Suzuki SR, Kuno A, Ozaki H. Cell-to-cell interaction analysis of prognostic ligand-receptor pairs in human pancreatic ductal adenocarcinoma. Biochem Biophys Rep. 2021;28:101126. https:\/\/doi.org\/10.1016\/j.bbrep.2021.101126.","journal-title":"Biochem Biophys Rep"},{"key":"8572_CR19","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1186\/s12967-024-05449-4","volume":"22","author":"M Ma","year":"2024","unstructured":"Ma M, Gu W, Liang Y, Han X, Zhang M, Xu M, et al. A novel model for predicting postoperative liver metastasis in R0 resected pancreatic neuroendocrine tumors: Integrating computational pathology and deep learning-radiomics. J translational Med. 2024;22:768. https:\/\/doi.org\/10.1186\/s12967-024-05449-4.","journal-title":"J translational Med"},{"key":"8572_CR20","doi-asserted-by":"publisher","first-page":"e430","DOI":"10.1097\/MPA.0000000000002463","volume":"54","author":"W Liu","year":"2025","unstructured":"Liu W, Li J, Yuan X, Chen C, Shen Y, Zhang X, et al. A novel deep learning-based pathomics score for prognostic stratification in pancreatic ductal adenocarcinoma. Pancreas. 2025;54:e430\u201341. https:\/\/doi.org\/10.1097\/MPA.0000000000002463.","journal-title":"Pancreas"},{"key":"8572_CR21","doi-asserted-by":"publisher","unstructured":"Hendifar AE, Krishna V, Krishna V, Zhang H, Tarsode A, Nimgaonkar V, et al. Development and validation of a computational histology artificial intelligence-powered predictive biomarker for selection of chemotherapy in advanced pancreatic cancer. J Clin Oncol: Off J Am Soc Clin Oncol. 2026;JCO2502199. https:\/\/doi.org\/10.1200\/JCO-25-02199.","DOI":"10.1200\/JCO-25-02199"},{"key":"8572_CR22","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.12688\/f1000research.73161.2","volume":"10","author":"MNM Sehmi","year":"2021","unstructured":"Sehmi MNM, Fauzi MFA, Ahmad WSHMW, Chan EWL. Pancreatic cancer grading in pathological images using deep learning convolutional neural networks. F1000Research. 2021;10:1057. https:\/\/doi.org\/10.12688\/f1000research.73161.2.","journal-title":"F1000Research"},{"key":"8572_CR23","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41571-024-00926-7","volume":"21","author":"J Chen","year":"2024","unstructured":"Chen J, Larsson L, Swarbrick A, Lundeberg J. Spatial landscapes of cancers: insights and opportunities. Nat Rev Clin Oncol. 2024;21:660\u201374. https:\/\/doi.org\/10.1038\/s41571-024-00926-7.","journal-title":"Nat Rev Clin Oncol"},{"key":"8572_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41580-024-00768-2","volume":"26","author":"GS Gulati","year":"2025","unstructured":"Gulati GS, D\u2019Silva JP, Liu Y, Wang L, Newman AM. Profiling cell identity and tissue architecture with single-cell and spatial transcriptomics. Nat Rev Mol Cell Biol. 2025;26:11\u201331. https:\/\/doi.org\/10.1038\/s41580-024-00768-2.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8572_CR25","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin D-C, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28:1747\u201356. https:\/\/doi.org\/10.1101\/gr.239244.118.","journal-title":"Genome Res"},{"key":"8572_CR26","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.1038\/s41467-023-40727-7","volume":"14","author":"S Zhang","year":"2023","unstructured":"Zhang S, Fang W, Zhou S, Zhu D, Chen R, Gao X, et al. Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis. Nat Commun. 2023;14:5123. https:\/\/doi.org\/10.1038\/s41467-023-40727-7.","journal-title":"Nat Commun"},{"key":"8572_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13073-024-01287-7","volume":"16","author":"S Kim","year":"2024","unstructured":"Kim S, Leem G, Choi J, Koh Y, Lee S, Nam S-H, et al. Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosis. Genome Med. 2024;16:20. https:\/\/doi.org\/10.1186\/s13073-024-01287-7.","journal-title":"Genome Med"},{"key":"8572_CR28","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1162\/NECO_a_00990","volume":"29","author":"W Rawat","year":"2017","unstructured":"Rawat W, Wang Z. Deep convolutional neural networks for image classification: a comprehensive review. Neural Comput. 2017;29:2352\u2013449. https:\/\/doi.org\/10.1162\/NECO_a_00990.","journal-title":"Neural Comput"},{"key":"8572_CR29","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1038\/s41401-020-00584-2","volume":"42","author":"H-F Hu","year":"2021","unstructured":"Hu H-F, Ye Z, Qin Y, Xu X-W, Yu X-J, Zhuo Q-F, et al. Mutations in key driver genes of pancreatic cancer: molecularly targeted therapies and other clinical implications. Acta Pharmacol Sin. 2021;42:1725\u201341. https:\/\/doi.org\/10.1038\/s41401-020-00584-2.","journal-title":"Acta Pharmacol Sin"},{"key":"8572_CR30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41575-019-0245-4","volume":"17","author":"L Buscail","year":"2020","unstructured":"Buscail L, Bournet B, Cordelier P. Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2020;17:153\u201368. https:\/\/doi.org\/10.1038\/s41575-019-0245-4.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8572_CR31","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1158\/2159-8290.CD-24-0100","volume":"14","author":"KL Donahue","year":"2024","unstructured":"Donahue KL, Watkoske HR, Kadiyala P, Du W, Brown K, Scales MK, et al. Oncogenic KRAS-Dependent Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth. Cancer Discov. 2024;14:1964\u201389. https:\/\/doi.org\/10.1158\/2159-8290.CD-24-0100.","journal-title":"Cancer Discov"},{"key":"8572_CR32","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s41575-021-00486-6","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Zeh HJ, Kang R, Kroemer G, Tang D. Cell death in pancreatic cancer: from pathogenesis to therapy. Nat Rev Gastroenterol Hepatol. 2021;18:804\u201323. https:\/\/doi.org\/10.1038\/s41575-021-00486-6.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8572_CR33","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ccell.2020.05.010","volume":"38","author":"LF Escobar-Hoyos","year":"2020","unstructured":"Escobar-Hoyos LF, Penson A, Kannan R, Cho H, Pan C-H, Singh RK, et al. Altered RNA splicing by mutant p53 activates oncogenic RAS signaling in pancreatic cancer. Cancer Cell. 2020;38:198\u2013e2118. https:\/\/doi.org\/10.1016\/j.ccell.2020.05.010.","journal-title":"Cancer Cell"},{"key":"8572_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41575-019-0109-y","volume":"16","author":"EA Collisson","year":"2019","unstructured":"Collisson EA, Bailey P, Chang DK, Biankin AV. Molecular subtypes of pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2019;16:207\u201320. https:\/\/doi.org\/10.1038\/s41575-019-0109-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8572_CR35","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.3390\/cells11142155","volume":"11","author":"JA McCubrey","year":"2022","unstructured":"McCubrey JA, Yang LV, Abrams SL, Steelman LS, Follo MY, Cocco L, et al. Effects of TP53 mutations and miRs on immune responses in the tumor microenvironment important in pancreatic cancer progression. Cells. 2022;11:2155. https:\/\/doi.org\/10.3390\/cells11142155.","journal-title":"Cells"},{"key":"8572_CR36","doi-asserted-by":"publisher","first-page":"e2025631118","DOI":"10.1073\/pnas.2025631118","volume":"118","author":"M Maddalena","year":"2021","unstructured":"Maddalena M, Mallel G, Nataraj NB, Shreberk-Shaked M, Hassin O, Mukherjee S, et al. TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment. Proc Natl Acad Sci U S A. 2021;118:e2025631118. https:\/\/doi.org\/10.1073\/pnas.2025631118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8572_CR37","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12957-025-03818-x","volume":"23","author":"Z Li","year":"2025","unstructured":"Li Z, Ren H, Zhang S, Sun C, Li Z, Niu P, et al. PD-L1 levels, TP53 mutation profiles, and survival outcomes in pancreatic cancer differ by immune-nutritional status. World J Surg Oncol. 2025;23:174. https:\/\/doi.org\/10.1186\/s12957-025-03818-x.","journal-title":"World J Surg Oncol"},{"key":"8572_CR38","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1038\/s41388-022-02368-w","volume":"41","author":"J Datta","year":"2022","unstructured":"Datta J, Bianchi A, De Castro Silva I, Deshpande NU, Cao LL, Mehra S, et al. Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer. Oncogene. 2022;41:3640\u201354. https:\/\/doi.org\/10.1038\/s41388-022-02368-w.","journal-title":"Oncogene"},{"key":"8572_CR39","doi-asserted-by":"publisher","first-page":"217134","DOI":"10.1016\/j.canlet.2024.217134","volume":"599","author":"S Zou","year":"2024","unstructured":"Zou S, Zhang L, Jiang C, Li F, Yang Y, Deng X, et al. Driver mutation subtypes involve with differentiated immunophenotypes influencing pancreatic cancer outcomes. Cancer Lett. 2024;599:217134. https:\/\/doi.org\/10.1016\/j.canlet.2024.217134.","journal-title":"Cancer Lett"},{"key":"8572_CR40","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1158\/0008-5472.CAN-24-2330","volume":"85","author":"EG Lloyd","year":"2025","unstructured":"Lloyd EG, Jihad M, Manansala JS, Li W, Cheng PSW, Mucciolo G, et al. SMAD4 and KRAS status shapes cancer cell-stromal cross-talk and therapeutic response in pancreatic cancer. Cancer Res. 2025;85:1368\u201389. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-2330.","journal-title":"Cancer Res"},{"key":"8572_CR41","doi-asserted-by":"publisher","first-page":"57351","DOI":"10.18632\/oncotarget.10344","volume":"7","author":"MA Pav\u00f3n","year":"2016","unstructured":"Pav\u00f3n MA, Arroyo-Solera I, C\u00e9spedes MV, Casanova I, Le\u00f3n X, Mangues R. uPA\/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy. Oncotarget. 2016;7:57351\u201366. https:\/\/doi.org\/10.18632\/oncotarget.10344.","journal-title":"Oncotarget"},{"key":"8572_CR42","doi-asserted-by":"publisher","first-page":"12515","DOI":"10.1038\/s41598-025-97629-5","volume":"15","author":"P An","year":"2025","unstructured":"An P, Wang J, Fan R. Identifying and validating PLAU as a potential prognostic biomarker for PDAC. Sci Rep. 2025;15:12515. https:\/\/doi.org\/10.1038\/s41598-025-97629-5.","journal-title":"Sci Rep"},{"key":"8572_CR43","doi-asserted-by":"publisher","first-page":"1079539","DOI":"10.3389\/fphar.2023.1079539","volume":"14","author":"X Xu","year":"2023","unstructured":"Xu X, Yu Y, Yang L, Wang B, Fan Y, Ruan B, et al. Integrated analysis of Dendrobium nobile extract Dendrobin A against pancreatic ductal adenocarcinoma based on network pharmacology, bioinformatics, and validation experiments. Front Pharmacol. 2023;14:1079539. https:\/\/doi.org\/10.3389\/fphar.2023.1079539.","journal-title":"Front Pharmacol"},{"key":"8572_CR44","doi-asserted-by":"publisher","first-page":"111612","DOI":"10.1016\/j.isci.2024.111612","volume":"28","author":"L Liu","year":"2025","unstructured":"Liu L, Huang H, Cheng B, Xie H, Peng W, Cui H, et al. Revealing the role of cancer-associated fibroblast senescence in prognosis and immune landscape in pancreatic cancer. iScience. 2025;28:111612. https:\/\/doi.org\/10.1016\/j.isci.2024.111612.","journal-title":"iScience"},{"key":"8572_CR45","doi-asserted-by":"publisher","first-page":"173225","DOI":"10.1016\/j.ejphar.2020.173225","volume":"880","author":"X Zhao","year":"2020","unstructured":"Zhao X, Liu Z, Ren Z, Wang H, Wang Z, Zhai J, et al. Triptolide inhibits pancreatic cancer cell proliferation and migration via down-regulating PLAU based on network pharmacology of Tripterygium wilfordii Hook F. Eur J Pharmacol. 2020;880:173225. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173225.","journal-title":"Eur J Pharmacol"},{"key":"8572_CR46","doi-asserted-by":"publisher","first-page":"1060957","DOI":"10.3389\/fimmu.2022.1060957","volume":"13","author":"SMZ Hosen","year":"2022","unstructured":"Hosen SMZ, Uddin MN, Xu Z, Buckley BJ, Perera C, Pang TCY, et al. Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU). Front Immunol. 2022;13:1060957. https:\/\/doi.org\/10.3389\/fimmu.2022.1060957.","journal-title":"Front Immunol"},{"key":"8572_CR47","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1002\/1878-0261.12705","volume":"14","author":"RIY Lieverse","year":"2020","unstructured":"Lieverse RIY, Marcus D, van der Wiel AMA, Van Limbergen EJ, Theys J, Yaromina A, et al. Human fibronectin extra domain B as a biomarker for targeted therapy in cancer. Mol Oncol. 2020;14:1555\u201368. https:\/\/doi.org\/10.1002\/1878-0261.12705.","journal-title":"Mol Oncol"},{"key":"8572_CR48","doi-asserted-by":"publisher","first-page":"17578","DOI":"10.1074\/jbc.M111.303131","volume":"287","author":"A Schiefner","year":"2012","unstructured":"Schiefner A, Gebauer M, Skerra A. Extra-domain B in oncofetal fibronectin structurally promotes fibrillar head-to-tail dimerization of extracellular matrix protein. J Biol Chem. 2012;287:17578\u201388. https:\/\/doi.org\/10.1074\/jbc.M111.303131.","journal-title":"J Biol Chem"},{"key":"8572_CR49","doi-asserted-by":"publisher","first-page":"217809","DOI":"10.1016\/j.canlet.2025.217809","volume":"625","author":"GP Nagaraju","year":"2025","unstructured":"Nagaraju GP, Saddala MS, Sarvesh S, Bandi DSR, Khaliq AM, Masood A, et al. Paricalcitol plus hydroxychloroquine enhances gemcitabine activity and induces mesenchymal to epithelial transition in pancreatic ductal adenocarcinoma: A single cell RNA-seq analysis. Cancer Lett. 2025;625:217809. https:\/\/doi.org\/10.1016\/j.canlet.2025.217809.","journal-title":"Cancer Lett"},{"key":"8572_CR50","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s11095-021-03083-z","volume":"38","author":"AL Schilb","year":"2021","unstructured":"Schilb AL, Ayat NR, Vaidya AM, Hertz LM, Hall RC, Scheidt JH, et al. Efficacy of targeted ECO\/miR-200c nanoparticles for modulating tumor microenvironment and treating triple negative breast cancer as non-invasively monitored by MR molecular imaging. Pharm Res. 2021;38:1405\u201318. https:\/\/doi.org\/10.1007\/s11095-021-03083-z.","journal-title":"Pharm Res"},{"key":"8572_CR51","doi-asserted-by":"publisher","first-page":"11127","DOI":"10.7150\/thno.47448","volume":"10","author":"A Vaidya","year":"2020","unstructured":"Vaidya A, Ayat N, Buford M, Wang H, Shankardass A, Zhao Y, et al. Noninvasive assessment and therapeutic monitoring of drug-resistant colorectal cancer by MR molecular imaging of extradomain-B fibronectin. Theranostics. 2020;10:11127\u201343. https:\/\/doi.org\/10.7150\/thno.47448.","journal-title":"Theranostics"},{"key":"8572_CR52","doi-asserted-by":"publisher","first-page":"109420","DOI":"10.1016\/j.intimp.2022.109420","volume":"113","author":"L Zhang","year":"2022","unstructured":"Zhang L, Zhang C, Xing Z, Lou C, Fang J, Wang Z, et al. Fibronectin 1 derived from tumor-associated macrophages and fibroblasts promotes metastasis through the JUN pathway in hepatocellular carcinoma. Int Immunopharmacol. 2022;113:109420. https:\/\/doi.org\/10.1016\/j.intimp.2022.109420.","journal-title":"Int Immunopharmacol"},{"key":"8572_CR53","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3390\/cells9081826","volume":"9","author":"A Vaidya","year":"2020","unstructured":"Vaidya A, Wang H, Qian V, Gilmore H, Lu Z-R. Overexpression of extradomain-B fibronectin is associated with invasion of breast cancer cells. Cells. 2020;9:1826. https:\/\/doi.org\/10.3390\/cells9081826.","journal-title":"Cells"},{"key":"8572_CR54","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1111\/cas.70041","volume":"116","author":"X Meng","year":"2025","unstructured":"Meng X, Yang X, Zhu J, Chen H, Luo C, Zhang F, et al. FN1 Immunoregulation in glioblastoma: insights from neutrophil-centric studies. Cancer Sci. 2025;116:1758\u201372. https:\/\/doi.org\/10.1111\/cas.70041.","journal-title":"Cancer Sci"},{"key":"8572_CR55","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13046-021-01946-2","volume":"40","author":"M Kemper","year":"2021","unstructured":"Kemper M, Schiecke A, Maar H, Nikulin S, Poloznikov A, Galatenko V, et al. Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression. J Exp Clin Cancer Res. 2021;40:214. https:\/\/doi.org\/10.1186\/s13046-021-01946-2.","journal-title":"J Exp Clin Cancer Res"},{"key":"8572_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-016-2474-y","author":"Z Khan","year":"2016","unstructured":"Khan Z, Marshall JF. The role of integrins in TGF\u03b2 activation in the tumour stroma. Cell Tissue Res. 2016;365:657\u2009\u2013\u200973. https:\/\/doi.org\/10.1007\/s00441-016-2474-y."},{"key":"8572_CR57","doi-asserted-by":"publisher","first-page":"eaax2770","DOI":"10.1126\/sciadv.aax2770","volume":"5","author":"PR Kuninty","year":"2019","unstructured":"Kuninty PR, Bansal R, De Geus SWL, Mardhian DF, Schnittert J, van Baarlen J, et al. ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer. Sci Adv. 2019;5:eaax2770. https:\/\/doi.org\/10.1126\/sciadv.aax2770.","journal-title":"Sci Adv"},{"key":"8572_CR58","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12943-024-02170-0","volume":"23","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Tao P, Zhang K, Chen L, Lv J, Chen Z, et al. Myofibroblast-derived extracellular vesicles facilitate cancer stemness of hepatocellular carcinoma via transferring ITGA5 to tumor cells. Mol Cancer. 2024;23:262. https:\/\/doi.org\/10.1186\/s12943-024-02170-0.","journal-title":"Mol Cancer"},{"key":"8572_CR59","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12885-021-07996-1","volume":"21","author":"H Zhu","year":"2021","unstructured":"Zhu H, Wang G, Zhu H, Xu A. ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors. BMC Cancer. 2021;21:269. https:\/\/doi.org\/10.1186\/s12885-021-07996-1.","journal-title":"BMC Cancer"},{"key":"8572_CR60","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1111\/cas.15388","volume":"113","author":"C Cheng","year":"2022","unstructured":"Cheng C, Liu D, Liu Z, Li M, Wang Y, Sun B, et al. Positive feedback regulation of lncRNA TPT1-AS1 and ITGB3 promotes cell growth and metastasis in pancreatic cancer. Cancer Sci. 2022;113:2986\u20133001. https:\/\/doi.org\/10.1111\/cas.15388.","journal-title":"Cancer Sci"},{"key":"8572_CR61","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s13402-011-0039-3","volume":"34","author":"S March\u00e1n","year":"2011","unstructured":"March\u00e1n S, P\u00e9rez-Torras S, Vidal A, Adan J, Mitjans F, Carb\u00f3 N, et al. Dual effects of \u03b23 integrin subunit expression on human pancreatic cancer models. Cell Oncol (Dordr). 2011;34:393\u2013405. https:\/\/doi.org\/10.1007\/s13402-011-0039-3.","journal-title":"Cell Oncol (Dordr)"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08572-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08572-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08572-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:01:43Z","timestamp":1790640103000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08572-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8572"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08572-6","relation":{"references":[{"id-type":"doi","id":"10.1007\/s00441-016-2474-y","asserted-by":"subject"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. The protocol was approved by the Medical Research Ethics Review Committee of the General Hospital of Ningxia Medical University (Approval No. KYLL-2025-0634). Written informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients provided written informed consent for the publication of anonymized clinical data and any potentially identifiable images.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1217"}}